Federal health agencies have found themselves navigating a complex communication landscape following an order from the Department of Health and Human Services (HHS) in January. The directive, initially issued by the Trump administration and continued under the new administration, called for an immediate pause on public communications. This pause was anticipated to end by February 1, yet several health reports remain in limbo. The temporary halt has led to confusion among study participants in National Institutes of Health (NIH)-funded trials and community members who support these endeavors.
The Centers for Disease Control and Prevention's (CDC) Morbidity and Mortality Weekly Report (MMWR) has resumed publication, marking a significant exception in the ongoing freeze. However, the HHS has made it clear that further exceptions will be selectively granted, particularly for matters deemed critical to preserving public health. This decision has sparked a wave of concern at academic medical centers, where faculty rely heavily on NIH-funded processes for their research.
“This is very serious in that the halting of these important meetings at the NIH has sowed confusion, chaos, and a lot of concern at academic medical centers where faculty rely on the NIH-funded process for their research work. This has also sowed confusion among study participants in NIH-funded trials and community members who support these trials on when funding decisions will be made,” – Gandhi
The pause has also significantly affected healthcare professionals' ability to conduct their duties effectively. Doctors, nurses, and public health leaders have reported difficulties in disseminating vital health information to the public. Compounding these challenges, the HHS has directed the CDC to remove webpages containing health information with diversity, equity, and inclusion (DEI) language.
“Not a day goes by when CDC isn’t tracking a potential threat to our health,” – Richard Besser
Despite these disruptions, the HHS has provided clear guidelines for agencies to seek approval for any other type of mass communication. The pause does not apply universally; exceptions exist for emergencies or announcements deemed mission-critical.
“HHS has issued a pause on mass communications and public appearances that are not directly related to emergencies or critical to preserving health. This is a short pause to allow the new team to set up a process for review and prioritization. There are exceptions for announcements that HHS divisions believe are mission critical, but they will be made on a case by case basis,” – HHS Office of Public Affairs spokesperson
Critics, including experts and consumer advocates, have voiced concerns over the impact of this pause on public awareness regarding pressing health issues such as rising respiratory virus cases and bans on harmful food additives. The disruption has been felt across academic circles as well, where the NIH-funded process is essential for research continuity.
“The worry is that the CDC needs to update numbers on their website (i.e., new H5N1 cases) on a daily basis, so any delay can be a problem,” – Gandhi
While some external communications are now exempt from the freeze, leading figures in health research call for a swift resolution to restore normalcy.
“There are several types of external communications that are no longer subject to the pause. All HHS divisions have been given clear guidance on how to seek approval for any other type of mass communication,” – Nixon
Leave a Reply